title: Re: Cost-effectiveness of prostate cancer screening: a simulation study based on ERSPC data.
authors.affiliation: Department of Urology (MAN), Spaarneziekenhuis, Hoofddorp, the Netherlands;. Department of General Practice, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands (MHB). mnoordzij@spaarneziekenhuis.nl marcoblanker@gmail.com.
authors.forename: M Arjen
authors.initials: MA
authors.lastname: Noordzij
authors.affiliation: Department of Urology (MAN), Spaarneziekenhuis, Hoofddorp, the Netherlands;. Department of General Practice, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands (MHB).
authors.forename: Marco H
authors.initials: MH
authors.lastname: Blanker
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D055088:Early Detection of Cancer / Q000191:economics* / Q000379:methods*; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000191:economics* / Q000379:methods*; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000191:economics* / Q000401:mortality*; D011788:Quality of Life; D019057:Quality-Adjusted Life Years
chemical_list: D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen